Viewing Study NCT00002166


Ignite Creation Date: 2025-12-24 @ 4:34 PM
Ignite Modification Date: 2026-05-08 @ 5:02 PM
Study NCT ID: NCT00002166
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease
Sponsor: Boehringer Ingelheim
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Nevirapine View
None Reverse Transcriptase Inhibitors View
None Anti-HIV Agents View